Symbol="ACRX"
AssetType="Common Stock"
Name="AcelRx Pharmaceuticals Inc"
Description="AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The company is headquartered in Redwood City, California."
CIK="1427925"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="351 GALVESTON DRIVE, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="14314700"
EBITDA="-29753000"
PERatio="0.138"
PEGRatio="0"
BookValue="2.646"
DividendPerShare="0"
DividendYield="0"
EPS="6.36"
RevenuePerShareTTM="0.274"
ProfitMargin="0"
OperatingMarginTTM="-15.31"
ReturnOnAssetsTTM="-0.408"
ReturnOnEquityTTM="0"
RevenueTTM="2024000"
GrossProfitTTM="-5030000"
DilutedEPSTTM="6.36"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.556"
AnalystTargetPrice="4"
TrailingPE="0.138"
ForwardPE="1.06"
PriceToSalesRatioTTM="11.8"
PriceToBookRatio="0.69"
EVToRevenue="10.28"
EVToEBITDA="0.309"
Beta="0.256"
num_52WeekHigh="7.17"
num_52WeekLow="0.55"
num_50DayMovingAverage="1.092"
num_200DayMovingAverage="1.463"
SharesOutstanding="16264900"
DividendDate="None"
ExDividendDate="None"
symbol="ACRX"
open="0.92"
high="0.92"
low="0.80"
price="0.88"
volume="186130.00"
latest_trading_day="2023-08-11"
previous_close="0.90"
change="-0.02"
change_percent="-1.9933%"
aroon_positive_momentum_days="49"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="49"
Volume_recent_avg="143854"
Change_recent_avg="0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.21"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="49"
Aroon_momentum_negative="51"
image_negative_thumbnail_id_1="1114"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0147.jpeg"
image_negative_thumbnail_id_2="1135"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0168.jpeg"
image_neutral_thumbnail_id_1="571"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_neutral_thumbnail_id_2="589"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_positive_thumbnail_id_1="949"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0111.jpeg"
image_positive_thumbnail_id_2="619"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0089.jpeg"
image_professor_thumbnail_id_1="1191"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
